FDAmanufacturing / CMC84% confidence
CDER’s Framework for Regulatory Advanced Manufacturing Evaluation (FRAME) Initiative
Source: FDA
Why This Matters
Why this matters: illustrates how regulators handled a comparable manufacturing / CMC decision relevant to pharmaceutical manufacturers; the same agency is already in play for this signal, so precedent weight is higher.
Regulatory Analysis
Supporting Context
- Therapeutic area
- Regulatory Affairs · Drug Manufacturing
- Sub-indication
- General
Related signal: FDA Proposes Streamlined Registration for Distributed Drug Manufacturing